Guarav Goyal

57PUBLICATIONS
193CO-AUTHORS
Haematological tumoursGenomicsAutoimmunityMedical infection agents (incl. prions)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Jun 24, 2026
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

|May 20, 2026
Mutational Profiling Links Biologically Relevant Variants to Multi-Systemic Rosai-Dorfman Disease.

|Apr 14, 2026
Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.

Paul G Kemps, Jennifer L Picarsic, Sébastien Héritier

|Mar 31, 2026
Consensus recommendations for malignant histiocytic neoplasms (histiocytic, Langerhans, and interdigitating dendritic cell sarcomas).

Gaurav Goyal, Oussama Abla, John K C Chan

|Feb 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challenge.

Vyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla

|Feb 09, 2026
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.

Catherine Diefenbach, Opeyemi Jegede, Victoria Wang

Pageof 10

Frequent Collaborators

17 joint publications

Aishwarya Ravindran

14 joint publications

Jithma P Abeykoon

13 joint publications

Ronald S Go

11 joint publications

Mithun Vinod Shah